152 related articles for article (PubMed ID: 38061665)
1. Decamethylcyclopentasiloxane developmental neurotoxicity testing.
Scialli AR
Reprod Toxicol; 2024 Jan; 123():108521. PubMed ID: 38061665
[No Abstract] [Full Text] [Related]
2. Nonhuman primates as animal models for toxicology research.
Burbacher TM; Grant KS
Curr Protoc Toxicol; 2001; Chapter 1():Unit1.1. PubMed ID: 23045019
[TBL] [Abstract][Full Text] [Related]
3. Recommendations for harmonization of data collection and analysis of developmental neurotoxicity endpoints in regulatory guideline studies: Proceedings of workshops presented at Society of Toxicology and joint Teratology Society and Neurobehavioral Teratology Society meetings.
Li AA; Sheets LP; Raffaele K; Moser V; Hofstra A; Hoberman A; Makris SL; Garman R; Bolon B; Kaufmann W; Auer R; Lau E; Vidmar T; Bowers WJ
Neurotoxicol Teratol; 2017 Sep; 63():24-45. PubMed ID: 28757310
[TBL] [Abstract][Full Text] [Related]
4. Developmental neurotoxicity testing: scientific approaches towards the next generation to protect the developing nervous system of children. An overview of the Developmental Neurotoxicity Symposium in 2011.
Aoyama H
Congenit Anom (Kyoto); 2012 Sep; 52(3):119-21. PubMed ID: 22925211
[TBL] [Abstract][Full Text] [Related]
5. Editorial: Developmental neurotoxicity.
Bal-Price A; Fritsche E
Toxicol Appl Pharmacol; 2018 Sep; 354():1-2. PubMed ID: 30030094
[No Abstract] [Full Text] [Related]
6. Design and validation of an ontology-driven animal-free testing strategy for developmental neurotoxicity testing.
Hessel EVS; Staal YCM; Piersma AH
Toxicol Appl Pharmacol; 2018 Sep; 354():136-152. PubMed ID: 29544899
[TBL] [Abstract][Full Text] [Related]
7. Developmental neurotoxicity testing: a path forward.
Crofton KM; Mundy WR; Shafer TJ
Congenit Anom (Kyoto); 2012 Sep; 52(3):140-6. PubMed ID: 22925214
[TBL] [Abstract][Full Text] [Related]
8. Comments from the Developmental Neurotoxicology Committee of the Japanese Teratology Society on the OECD Guideline for the Testing of Chemicals, Proposal for a New Guideline 426, Developmental Neurotoxicity Study, Draft Document (October 2006 version), and on the Draft Document of the Retrospective Performance Assessment of the Draft Test Guideline 426 on Developmental Neurotoxicity.
Ema M; Fukui Y; Aoyama H; Fujiwara M; Fuji J; Inouye M; Iwase T; Kihara T; Oi A; Otani H; Shinomiya M; Sugioka K; Yamano T; Yamashita KH; Tanimura T;
Congenit Anom (Kyoto); 2007 Jun; 47(2):74-6. PubMed ID: 17504392
[TBL] [Abstract][Full Text] [Related]
9. Behavioral toxicology in the 21st century: challenges and opportunities for behavioral scientists. Summary of a symposium presented at the annual meeting of the neurobehavioral teratology society, June, 2009.
Bushnell PJ; Kavlock RJ; Crofton KM; Weiss B; Rice DC
Neurotoxicol Teratol; 2010; 32(3):313-28. PubMed ID: 20171276
[TBL] [Abstract][Full Text] [Related]
10. A better approach to in vivo developmental neurotoxicity assessment: Alignment of rodent testing with effects seen in children after neurotoxic exposures.
Vorhees CV; Sprowles JN; Regan SL; Williams MT
Toxicol Appl Pharmacol; 2018 Sep; 354():176-190. PubMed ID: 29544898
[TBL] [Abstract][Full Text] [Related]
11. Report of the thirty-third annual meeting of the Neurobehavioral Teratology Society, 2009.
Grant KS
Neurotoxicol Teratol; 2010; 32(2):295-6. PubMed ID: 20097284
[No Abstract] [Full Text] [Related]
12. Strategies to improve the regulatory assessment of developmental neurotoxicity (DNT) using in vitro methods.
Bal-Price A; Pistollato F; Sachana M; Bopp SK; Munn S; Worth A
Toxicol Appl Pharmacol; 2018 Sep; 354():7-18. PubMed ID: 29476865
[TBL] [Abstract][Full Text] [Related]
13. Recommendation on test readiness criteria for new approach methods in toxicology: Exemplified for developmental neurotoxicity.
Bal-Price A; Hogberg HT; Crofton KM; Daneshian M; FitzGerald RE; Fritsche E; Heinonen T; Hougaard Bennekou S; Klima S; Piersma AH; Sachana M; Shafer TJ; Terron A; Monnet-Tschudi F; Viviani B; Waldmann T; Westerink RHS; Wilks MF; Witters H; Zurich MG; Leist M
ALTEX; 2018; 35(3):306-352. PubMed ID: 29485663
[TBL] [Abstract][Full Text] [Related]
14. Toxicogenomic approaches in developmental toxicology testing.
Robinson JF; Piersma AH
Methods Mol Biol; 2013; 947():451-73. PubMed ID: 23138921
[TBL] [Abstract][Full Text] [Related]
15. In vivo models of developmental toxicology.
Hansen JM
Methods Mol Biol; 2012; 889():7-13. PubMed ID: 22669656
[TBL] [Abstract][Full Text] [Related]
16. Consensus statement on the need for innovation, transition and implementation of developmental neurotoxicity (DNT) testing for regulatory purposes.
Fritsche E; Grandjean P; Crofton KM; Aschner M; Goldberg A; Heinonen T; Hessel EVS; Hogberg HT; Bennekou SH; Lein PJ; Leist M; Mundy WR; Paparella M; Piersma AH; Sachana M; Schmuck G; Solecki R; Terron A; Monnet-Tschudi F; Wilks MF; Witters H; Zurich MG; Bal-Price A
Toxicol Appl Pharmacol; 2018 Sep; 354():3-6. PubMed ID: 29447839
[TBL] [Abstract][Full Text] [Related]
17. International STakeholder NETwork (ISTNET) for creating a developmental neurotoxicity testing (DNT) roadmap for regulatory purposes.
Crofton K; Fritsche E; Ylikomi T; Bal-Price A
ALTEX; 2014; 31(2):223-4. PubMed ID: 24794006
[No Abstract] [Full Text] [Related]
18. Advancing the science of developmental neurotoxicity (DNT): testing for better safety evaluation.
Bal-Price AK; Coecke S; Costa L; Crofton KM; Fritsche E; Goldberg A; Grandjean P; Lein PJ; Li A; Lucchini R; Mundy WR; Padilla S; Persico AM; Seiler AE; Kreysa J
ALTEX; 2012; 29(2):202-15. PubMed ID: 22892558
[No Abstract] [Full Text] [Related]
19. Developmental neurotoxicity guideline study: issues with methodology, evaluation and regulation.
Tsuji R; Crofton KM
Congenit Anom (Kyoto); 2012 Sep; 52(3):122-8. PubMed ID: 22925212
[TBL] [Abstract][Full Text] [Related]
20. Teratology studies in the rat.
Leroy M; Allais L
Methods Mol Biol; 2013; 947():95-109. PubMed ID: 23138899
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
